The Barchart Chart of the Day belongs to Xenon Pharmaceuticals (XENE).
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refers to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphans as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
Barchart technical indicators:
100% technical buy signals
387.20+ Weighted Alpha
338.18% gain in the last year
Trend Spotter buy signal
Above its 20, 50 and 100 day moving averages
6 new highs and up 25.52% in the last month
Relative Strength Index 71.71%
Technical support level at 10.20
Recently traded at 12.10 with a 50 day moving average of 8.84
Fundamental factors:
Market Cap $156 million
Revenue expected to grow 1295.50% this year but shrink 23.30% next year
Earnings estimated to increase 17.00% this year, decrease by 19.70% next year but continue to compound at an annual rate of 57.80% for the next 5 years
Wall Street analysts presently have 2 strong buy and 1 buy recommendation in place on the stock
